Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multiomics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries.
$277M sweet spot round size
2017
$277M
from 2 investors over 1 rounds
Element Biosciences raised $277M on August 11, 2024
Investors: Wellington Management and + 4 Other investors